FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer.

Saved in:
Bibliographic Details
Title: FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer.
Authors: Castillo-Castrejon M; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA., Sankofi BM; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA., Murguia SJ; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA., Udeme AA; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA., Cen HH; Life Sciences Institute, University of British Columbia, Vancouver, Canada., Xia YH; Life Sciences Institute, University of British Columbia, Vancouver, Canada., Thomas NS; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA., Berry WL; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA., Jones KL; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA., Richard VR; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital and McGill University, Montreal, QC, Canada., Zahedi RP; Manitoba Centre for Proteomics and Systems Biology, Winnipeg, MB, R3E 3P4, Canada.; Department of Internal Medicine, University of Manitoba, Winnipeg, MB, R3E 3P4, Canada.; Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, MB, R3E 0J9, Canada.; CancerCare Manitoba Research Institute, Winnipeg, MB, R3E 0V9, Canada., Borchers CH; Manitoba Centre for Proteomics and Systems Biology, Winnipeg, MB, R3E 3P4, Canada.; Gerald Bronfman Department of Oncology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, H3T 1E2, Canada.; Division of Experimental Medicine, McGill University, Montreal, QC, H4A 3J1, Canada.; Department of Pathology, McGill University, Montreal, QC, H3A 2B4, Canada., Johnson JD; Life Sciences Institute, University of British Columbia, Vancouver, Canada., Wellberg EA; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA. elizabeth-wellberg@ouhsc.edu.
Source: Breast cancer research : BCR [Breast Cancer Res] 2023 Aug 22; Vol. 25 (1), pp. 99. Date of Electronic Publication: 2023 Aug 22.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1465-542X
DOI:10.1186/s13058-023-01699-0